selling semaglutide A South African court has ordered pharmacy group iDexis to stop semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company FDA Warns Online Vendors Selling

We work extensively to guarantee product quality, potency and transparency for you

No product or service offered by the Company through its Website is intended to offer any medical advice, suggestion, diagnosis, cure, or relief for any medical issue whatsoever and is sold on the single premise of research only

Adverse events should be reported under the MHRAs Yellow Card scheme, but may be caused by other factors, including pre-existing conditions

The indication, not just the drug, determines where the PA goes, how it's documented, and what it costs the patient

Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials